EUVIMEDEUVIMED entdecken
Crossref

The Study of the Antitumor Effects and Molecular Mechanisms of Byakangelicol on HepG2 Cells

Chang Wang, Xiao-Yu Jin, Ying-Hua Luo, Nan Wu, Yan-Jun Tang, Yan-Zhi Liu, Tian-Zhu Li, Cheng-Hao Jin iD

Journal of Biochemical and Molecular Toxicology · 2026-04 · 40 (4)

DOI: 10.1002/jbt.70819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 27.03.2026. Verfasst von Chang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Engineering, College of Food Science, Heilongjiang Bayi Agricultural University, Daqing, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Apoptosis, Carcinoma, Hepatocellular, Antineoplastic Agents. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomouss Region, Heilongjiang Province Key Research and Development Plan Guidance Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Byakangelicol (BYA) belongs to coumarins, which have anti‐inflammatory and anti‐tumor pharmacological properties, but its inhibitory effect on liver cancer and its mechanism are still indistinct. This study explored the mechanism of action by which BYA affects hepatocellular carcinoma (HCC). Cell cytotoxic and apoptosis assay results showed that BYA effectively killed three kinds of HCC cells and induced mitochondrial pathway apoptosis of HepG2 cells. Furthermore, the results of network pharmacological analysis, flow cytometry and western blot assays demonstrated that BYA can induced reactive oxygen species (ROS) accumulation, which in turn upregulated the phosphorylation expression of JNK and p38 while downregulating the phosphorylation expression of AKT, ERK, and STAT3. Meanwhile, the expression of these proteins was reversed after MAPK inhibitors pretreatment. Cell cycle and cell metastasis assay results showed that BYA can induce G2/M phase arrest and inhibit cell metastasis. At the same time, the expression of related proteins was reversed after ROS inhibitors ( N ‐Acetyl‐ l ‐cysteine) pretreatment. The research results reveal that BYA can cause the accumulation of ROS within cells, and induce apoptosis in HepG2 cells through the mitochondrial pathway, thereby leading to cell cycle arrest at the G2/M phase and inhibition of cell migration ability. This study provides theoretical support for the clinical application of BYA in the treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsApoptosisCarcinoma, HepatocellularAntineoplastic AgentsHumansHep G2 CellsReactive Oxygen SpeciesCell Movement

Stichwörter der Autor:innen

ROSbyakangelicolcell apoptosiscell cyclecell migrationhepatocellular carcinoma

Substanzen

Reactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Food Science and Engineering, College of Food Science, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Agricultural Products and Proceed Products Supervision and Testing Center, Ministry of Agriculture, Daqing, China.
  • Department of CT, Daqing Oilfield General Hospital, Daqing, China.
  • Department of Grass Science, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Department of Biochemistry and Molecular Biology, College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
  • National Coarse Cereals Engineering Research Center, Daqing, China.

ORCID-Profile: Cheng-Hao Jin

Förderung

  • National Natural Science Foundation of China
  • Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomouss Region
  • Heilongjiang Province Key Research and Development Plan Guidance Project

Zitieren

APA

Wang, C., Jin, X. Y., Luo, Y. H., Wu, N., Tang, Y. J., Liu, Y. Z., Li, T. Z., & Jin, C. H. (2026). The Study of the Antitumor Effects and Molecular Mechanisms of Byakangelicol on HepG2 Cells. Journal of Biochemical and Molecular Toxicology, 40(4). https://doi.org/10.1002/jbt.70819

Vancouver

Wang C, Jin XY, Luo YH, Wu N, Tang YJ, Liu YZ, et al. The Study of the Antitumor Effects and Molecular Mechanisms of Byakangelicol on HepG2 Cells. Journal of Biochemical and Molecular Toxicology. 2026;40(4). doi:10.1002/jbt.70819

BibTeX
@article{Wang2026,
  author = {Wang, Chang and Jin, Xiao-Yu and Luo, Ying-Hua and Wu, Nan and Tang, Yan-Jun and Liu, Yan-Zhi and Li, Tian-Zhu and Jin, Cheng-Hao},
  title = {The Study of the Antitumor Effects and Molecular Mechanisms of Byakangelicol on HepG2 Cells},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {4},
  doi = {10.1002/jbt.70819}
}
Kostenlos starten →